Muscle Relaxant Drugs Market is expected to generate a revenue of USD 6.59 Billion by 2031, Globally, at 5.4 percent CAGR Verified Market Research
| SUHIX Fund | USD 46.65 0.13 0.28% |
Slightly above 55% of Deutsche Health's investor base is interested to short. The analysis of overall sentiment of trading Deutsche Health And mutual fund suggests that many investors are impartial at this time. Deutsche Health's investing sentiment can be driven by a variety of factors including economic data, Deutsche Health's earnings reports, geopolitical events, and overall market trends.
Deutsche |
The Global Muscle Relaxant Drugs Market Size is projected to grow at a CAGR of 5.40 percent from 2024 to 2031, according to a new report published by Verified Market Research. The report reveals that the market was valued at USD 4.33 Billion in 2024 and is expected to reach USD 6.59 Billion by the end of the forecast period.
Read at finance.yahoo.com
 |
Deutsche Health Fundamental Analysis
We analyze Deutsche Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deutsche Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deutsche Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Ten Year Return
Ten Year Return Comparative Analysis
Deutsche Health is currently under evaluation in ten year return among similar funds. Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
Deutsche Health And Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Deutsche Health mutual fund to make a market-neutral strategy. Peer analysis of Deutsche Health could also be used in its relative valuation, which is a method of valuing Deutsche Health by comparing valuation metrics with similar companies.
Peers
Deutsche Health Related Equities
| KTCCX | Deutsche Science | 0.75 | ||||
| KTCSX | Deutsche Science | 0.71 | ||||
| KTCIX | Deutsche Science | 0.70 | ||||
| KTCAX | Deutsche Science | 0.69 | ||||
| KTRAX | Deutsche Global | 0.59 | ||||
| KTRCX | Deutsche Global | 0.59 | ||||
| GCGGX | Deutsche Gnma | 0.34 | ||||
| SRMAX | Deutsche Short | 0.10 | ||||
| SRMCX | Deutsche Short | 0.10 | ||||
| SRMSX | Deutsche Short-term | 0.10 |
Other Information on Investing in Deutsche Mutual Fund
Deutsche Health financial ratios help investors to determine whether Deutsche Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deutsche with respect to the benefits of owning Deutsche Health security.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |